{"groups":[{"description":"Patients receive etoposide IV over 4 hours on day 0, filgrastim SC QD beginning day 1, and plerixafor SC 15-18 hours prior to apheresis. Patients unable to achieve target collection of \\>= 8 x 10\\^6 CD34+ cells/kg receive another dose of plerixafor followed by apheresis. Following the second apheresis, patients achieving =\\< 2 x 10\\^6 CD34+ cells/kg may continue filgrastim with plerixafor and continue collection according to the attending physician.\n\nplerixafor: Given SC\n\nfilgrastim: Given SC\n\netoposide: Given IV\n\nleukapheresis: Undergo apheresis","id":"FG000","title":"Treatment (Stem Cell Supermobilization)"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"unable to collect cells"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"25"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"24"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}